Drug Discovery Collaboration Announced By Galapagos And Cystic Fibrosis Foundation Therapeutics
Galapagos NV (Euronext & LSE: GLPG) and Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the non-profit affiliate of the Cystic Fibrosis Foundation, have announced a new collaboration aimed at discovering new treatments for cystic fibrosis. This new agreement between CFFT and Galapagos’ BioFocus DPI service division is worth up to 5.5 million euros ($8.1 million U.S. dollars) for Galapagos. [click link for full article]
More: continued here
Filed under: Biology on December 2nd, 2007